FGFR3 GENE FUSIONS
Clinical trials for FGFR3 GENE FUSIONS explained in plain language.
Never miss a new study
Get alerted when new FGFR3 GENE FUSIONS trials appear
Sign up with your email to follow new studies for FGFR3 GENE FUSIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets genetic drivers in tough-to-treat cancers
Disease control Recruiting nowThis is the first study in people testing an experimental pill called TYRA-430. It aims to find a safe dose and see if it can help control advanced liver cancer and other solid tumors that have specific genetic changes in the FGF/FGFR pathway. The study will enroll about 100 adul…
Matched conditions: FGFR3 GENE FUSIONS
Phase: PHASE1 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Targeted pill trial aims to wipe out early bladder tumors
Disease control Recruiting nowThis study is testing an oral medication called TYRA-300 for adults with early-stage, non-muscle-invasive bladder cancer that has a specific genetic change (FGFR3). The goal is to see if the pill can completely eliminate visible tumors left in the bladder after a biopsy. Research…
Matched conditions: FGFR3 GENE FUSIONS
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Mar 09, 2026 14:24 UTC